Cargando…
Anodal Transcranial Direct Current Stimulation Can Improve Spatial Learning and Memory and Attenuate Aβ(42) Burden at the Early Stage of Alzheimer’s Disease in APP/PS1 Transgenic Mice
Alzheimer’s disease (AD) is an irreversible progressive neurodegenerative disease. Intervention in the early stage of AD is a new path for AD treatment that is being explored. The behavioral and pathological effects of anodal transcranial direct current stimulation (AtDCS) at the early stage of AD i...
Autores principales: | Luo, Yinpei, Yang, Wenjuan, Li, Nian, Yang, Xiufang, Zhu, Binglian, Wang, Cong, Hou, Wensheng, Wang, Xing, Wen, Huizhong, Tian, Xuelong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239315/ https://www.ncbi.nlm.nih.gov/pubmed/32595486 http://dx.doi.org/10.3389/fnagi.2020.00134 |
Ejemplares similares
-
Anodal transcranial direct current stimulation alleviates cognitive impairment in an APP/PS1 model of Alzheimer’s disease in the preclinical stage
por: Luo, Yin-Pei, et al.
Publicado: (2022) -
Transcranial Direct Current Stimulation Alleviates Neurovascular Unit Dysfunction in Mice With Preclinical Alzheimer’s Disease
por: Luo, Yinpei, et al.
Publicado: (2022) -
Naringin Dihydrochalcone Ameliorates Cognitive Deficits and Neuropathology in APP/PS1 Transgenic Mice
por: Yang, Wenjuan, et al.
Publicado: (2018) -
Corrigendum: Anodal transcranial direct current stimulation alleviates cognitive impairment in an APP/PS1 model of Alzheimer’s disease in the preclinical stage
Publicado: (2023) -
Effects of (−)Epicatechin on the Pathology of APP/PS1 Transgenic Mice
por: Zeng, Yue-Qin, et al.
Publicado: (2014)